Both in Pharmaceuticals
PERRIGO vs Immunome
Over the past year PRGO returned −23.3% and IMNM returned +15.2%; their daily moves had a correlation of 0.18.
PRGO −23.3% IMNM +15.2%Growth of $1, one year, split-adjusted
| Metric | PRGO | IMNM |
|---|---|---|
| Price | $15.75 | $19.59 |
| Market cap | $2.19B | $2.31B |
| Today | −0.19% | +7.58% |
| 1 month | +10.4% | −6.3% |
| 6 months | +38.3% | −16.0% |
| Year to date | +13.1% | −8.8% |
| 1 year | −23.7% | +22.6% |
| Revenue growth (YoY) | −3.2% | −100.0% |
| Gross margin | 30.7% | — |
| Net margin | 7.3% | — |
| P/E (TTM) | — | — |
| Price / sales | 0.5× | — |
| Net cash | -$2.90B | $520.0M |
| Dividend yield | 7.37% | — |
| Volatility (60d) | 40.4% | 57.6% |
| Short % of float | 17.5% | 17.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).